Details for New Drug Application (NDA): 011620
✉ Email this page to a colleague
NDA 011620 describes CARDIOGRAFIN, which is a drug marketed by Bracco and is included in one NDA. Additional details are available on the CARDIOGRAFIN profile page.
The generic ingredient in CARDIOGRAFIN is diatrizoate meglumine. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
The generic ingredient in CARDIOGRAFIN is diatrizoate meglumine. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
Summary for 011620
| Tradename: | CARDIOGRAFIN |
| Applicant: | Bracco |
| Ingredient: | diatrizoate meglumine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011620
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 85% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
